PSMA PET in Clinical Practice: Optimizing Prostate Cancer Management
Jaideep Sohi, MD, and Jeremie Calais, MD, examine advanced prostate cancer imaging techniques, focusing on PSMA PET and gallium-based modalities, their role in detecting oligometastatic disease, integration with multidisciplinary care teams, and strategies for optimizing clinical outcomes across the spectrum of prostate cancer management.
EP. 1: PSMA PET vs. Gallium-Based PET: Navigating NCCN Guidelines in Prostate Cancer Imaging
September 4th 2024Jaideep Sohi, MD, and Jeremie Calais, MD, examine the comparative merits of PSMA PET and Gallium-Based PET while exploring the application of NCCN Guidelines in prostate cancer imaging protocols.
EP. 4: Understanding Oligometastatic Disease in Prostate Cancer: Insights from PSMA PET Imaging
September 11th 2024Key opinion leaders examine the role of advanced imaging agents, particularly PSMA PET and other radiotracers, in identifying and defining oligometastatic disease in patients with prostate cancer.
